The CD44+/CD24- phenotype is enriched in basal-like breast tumors
-
* Corresponding author: Gabriella Honeth gabriella.honeth@med.lu.se
Breast Cancer Research 2008, 10:R53 doi:10.1186/bcr2108
Accesses
- Last 30 days: 163 accesses
- Last year: 2243 accesses
- All time: 11452 accesses
Cited by
BioMed Central: 14 citations
|
Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance H Raza Ali, Sarah-Jane Dawson, Fiona M Blows, Elena Provenzano, Paul D Pharoah, Carlos Caldas Breast Cancer Research 2011, 13:R118 (23 November 2011) |
|
Eleonor Olsson, Gabriella Honeth, Pär-Ola Bendahl, Lao H Saal, Sofia Gruvberger-Saal, Markus Ringnér, Johan Vallon-Christersson, Göran Jönsson, Karolina Holm, Kristina Lövgren, Mårten Fernö, Dorthe Grabau, Åke Borg, Cecilia Hegardt BMC Cancer 2011, 11:418 (29 September 2011) |
|
Generation of tumor-initiating cells by exogenous delivery of OCT4 transcription factor Adriana S Beltran, Ashley G Rivenbark, Bryan T Richardson, Xinni Yuan, Haili Quian, John P Hunt, Eric Zimmerman, Lee M Graves, Pilar Blancafort Breast Cancer Research 2011, 13:R94 (27 September 2011) |
|
Differential expression of HIF-1α in CD44+CD24-/low breast ductal carcinomas João Oliveira-Costa, Juliana S Zanetti, Giórgia G Silveira, Danilo F Soave, Lucinei R Oliveira, Verônica A Zorgetto, Fernando A Soares, Sérgio Zucoloto, Alfredo Ribeiro-Silva Diagnostic Pathology 2011, 6:73 (8 August 2011) |
|
Caitlin D May, Nathalie Sphyris, Kurt W Evans, Steven J Werden, Wenjun Guo, Sendurai A Mani Breast Cancer Research 2011, 13:202 (8 February 2011) |
|
HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer Leonard Da Silva, Peter T Simpson, Chanel E Smart, Sibylle Cocciardi, Nic Waddell, Annette Lane, Brian J Morrison, Ana Vargas, Sue Healey, Jonathan Beesley, Pria Pakkiri, Suzanne Parry, Nyoman Kurniawan, Lynne Reid, Patricia Keith, Paulo Faria, Emilio Pereira, Alena Skalova, Michael Bilous, Rosemary L Balleine, Hongdo Do, Alexander Dobrovic, Stephen Fox, Marcello Franco, Brent Reynolds, Kum Khanna, Margaret Cummings, Georgia Chenevix-Trench, Sunil R Lakhani Breast Cancer Research 2010, 12:R46 (6 July 2010) Deregulated epidermal growth factor receptors are involved in the colonisation of brain metastases from breast cancer, but downstream oncogenic mutations, which may drive treatment resistance, also warrant further investigation.
|
|
Göran Jönsson, Johan Staaf, Johan Vallon-Christersson, Markus Ringnér, Karolina Holm, Cecilia Hegardt, Haukur Gunnarsson, Rainer Fagerholm, Carina Strand, Bjarni A Agnarsson, Outi Kilpivaara, Lena Luts, Päivi Heikkilä, Kristiina Aittomäki, Carl Blomqvist, Niklas Loman, Per Malmström, Håkan Olsson, Oskar Th Johannsson, Adalgeir Arason, Heli Nevanlinna, Rosa B Barkardottir, Åke Borg Breast Cancer Research 2010, 12:R42 (24 June 2010) The identification of six subtypes of breast cancer - differing in biology, genomic alterations and patient outcome - may prove useful for understanding tumor development and for prognostic and treatment prediction purposes.
|
|
Johan Staaf, Göran Jönsson, Markus Ringnér, Johan Vallon-Christersson, Dorthe Grabau, Adalgeir Arason, Haukur Gunnarsson, Bjarni A Agnarsson, Per-Olof Malmström, Oskar Johannsson, Niklas Loman, Rosa B Barkardottir, Åke Borg Breast Cancer Research 2010, 12:R25 (6 May 2010) A survey of copy number alterations in HER2+ breast tumors using a combination of array comparative genomic hybridization and gene expression analyses pinpoints significant genomic aberrations, including potentially novel therapeutic targets.
|
|
Dynamic regulation of CD24 and the invasive, CD44posCD24neg phenotype in breast cancer cell lines Matthew J Meyer, Jodie M Fleming, Mustapha A Ali, Mitchell W Pesesky, Erika Ginsburg, Barbara K Vonderhaar Breast Cancer Research 2009, 11:R82 (11 November 2009) |
|
Julian Puppe, Rinske Drost, Xiaoling Liu, Simon A Joosse, Bastiaan Evers, Paulien Cornelissen-Steijger, Petra Nederlof, Qiang Yu, Jos Jonkers, Maarten van Lohuizen, Alexandra M Pietersen Breast Cancer Research 2009, 11:R63 (26 August 2009) |
|
Breast cancer stem cells: tools and models to rely on Emmanuelle Charafe-Jauffret, Christophe Ginestier, Daniel Birnbaum BMC Cancer 2009, 9:202 (25 June 2009) |
|
Number crunching in the cancer stem cell market Malcolm R Alison, Shahriar Islam, Susan ML Lim Breast Cancer Research 2009, 11:302 (24 April 2009) |
|
Breast cancer stem cell markers – the rocky road to clinical applications Gabriela Dontu Breast Cancer Research 2008, 10:110 (15 September 2008) |
|
Breast cancer stem cells: implications for therapy of breast cancer Brian J Morrison, Chris W Schmidt, Sunil R Lakhani, Brent A Reynolds, J Alejandro Lopez Breast Cancer Research 2008, 10:210 (22 July 2008) |